Reuters logo
1 个月前
BRIEF-Agile therapeutics resubmits new drug application for transdermal contraceptive patch
2017年6月27日 / 中午12点19分 / 1 个月前

BRIEF-Agile therapeutics resubmits new drug application for transdermal contraceptive patch

1 分钟阅读

June 27 (Reuters) - Agile Therapeutics Inc:

* Agile therapeutics resubmits new drug application (NDA) for its transdermal contraceptive patch, Twirla®

* Agile therapeutics -resubmitted NDA includes efficacy, safety data from new phase 3 clinical trial, requested manufacturing information, and summary response to CRL Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below